None listed
Conditions
Brief summary
The hypothesis is that fatty acids consumed in flaxseed oil are converted in the body to novel fatty acid oxidation products. The purpose of the study is to determine whether these fatty acid oxidation products can be measured in the blood and urine of men following supplementation with flaxseed oil for 4 weeks. The study subjects, the investigators and the statistical analyst are blinded to the treatment allocation.
Interventions
The study is placebo-controlled, double-blind, of parallel design. Participants will be randomly allocated to take capsules of 9 X 1gm per day of flaxseed oil (By Nature, Perth, Western Australia), orally for 4 weeks, while maintaining their normal dietary habits and physically activity.
Sponsors
Dr Trevor Mori
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used)
Eligibility
Sex/Gender
Male
Age
20 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
Healthy, non-smoking, non-diabetic, not taking medication or dietary supplements.
Exclusion criteria
Angina pectoris; major surgery or a cardiovascular event or diagnosis <12 months; liver or kidney disease; current smokers; fasting blood triglycerides >1.8 mmol/L; 2 or less fish meals per week or regularly taking fish oil capsules.
Outcome results
None listed